Pain in Osteoporosis: Current and Future Strategies.

IF 3.8 3区 医学 Q2 GERIATRICS & GERONTOLOGY
Drugs & Aging Pub Date : 2025-09-01 Epub Date: 2025-07-09 DOI:10.1007/s40266-025-01225-1
Giada Barresi, Cecilia Oliveri, Nunziata Morabito, Herbert Ryan Marini, Anastasia Xourafa, Agostino Gaudio, Gabriella Martino, Letteria Minutoli, Antonino Catalano
{"title":"Pain in Osteoporosis: Current and Future Strategies.","authors":"Giada Barresi, Cecilia Oliveri, Nunziata Morabito, Herbert Ryan Marini, Anastasia Xourafa, Agostino Gaudio, Gabriella Martino, Letteria Minutoli, Antonino Catalano","doi":"10.1007/s40266-025-01225-1","DOIUrl":null,"url":null,"abstract":"<p><p>Osteoporosis is the most common metabolic bone disease and the main cause of fractures in older adults. Although it is commonly described as a silent disease, the bone pain caused by fragility fractures is its main symptom. Besides acute pain, fragility fractures may trigger a sequence of events that perpetuate and progress into chronic pain. The pathogenesis of musculoskeletal pain in patients with osteoporosis is complex and largely depends on skeletal and muscular changes, unbalanced bone turn-over, alterations in bone innervation, and central sensitization. Pain, in the context of bone fragility, represents an outstanding contributor to functional limitation, disability, and impaired quality of life. Pain prevention is closely related to identification of osteoporosis risk factors and early diagnosis and treatment of bone fragility. The management of pain in patients with severe osteoporosis also benefits from a multidimensional approach combining nonpharmacological with pharmacological therapies (e.g., physical exercise, nutrition, analgesics, and anti-osteoporotic drugs, as appropriate). This review aims to examine the mechanisms of pain in osteoporosis and provide an evidence-based overview of current and emerging treatment strategies.</p>","PeriodicalId":11489,"journal":{"name":"Drugs & Aging","volume":" ","pages":"821-836"},"PeriodicalIF":3.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs & Aging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40266-025-01225-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Osteoporosis is the most common metabolic bone disease and the main cause of fractures in older adults. Although it is commonly described as a silent disease, the bone pain caused by fragility fractures is its main symptom. Besides acute pain, fragility fractures may trigger a sequence of events that perpetuate and progress into chronic pain. The pathogenesis of musculoskeletal pain in patients with osteoporosis is complex and largely depends on skeletal and muscular changes, unbalanced bone turn-over, alterations in bone innervation, and central sensitization. Pain, in the context of bone fragility, represents an outstanding contributor to functional limitation, disability, and impaired quality of life. Pain prevention is closely related to identification of osteoporosis risk factors and early diagnosis and treatment of bone fragility. The management of pain in patients with severe osteoporosis also benefits from a multidimensional approach combining nonpharmacological with pharmacological therapies (e.g., physical exercise, nutrition, analgesics, and anti-osteoporotic drugs, as appropriate). This review aims to examine the mechanisms of pain in osteoporosis and provide an evidence-based overview of current and emerging treatment strategies.

骨质疏松的疼痛:当前和未来的策略。
骨质疏松症是老年人最常见的代谢性骨病,也是导致骨折的主要原因。虽然它通常被描述为一种无声的疾病,但由脆性骨折引起的骨痛是其主要症状。除了急性疼痛外,脆性骨折还可能引发一系列事件,这些事件持续并发展为慢性疼痛。骨质疏松症患者肌肉骨骼疼痛的发病机制是复杂的,很大程度上取决于骨骼和肌肉的变化、不平衡的骨翻转、骨神经支配的改变和中枢致敏。在骨骼脆弱的情况下,疼痛是导致功能限制、残疾和生活质量受损的重要因素。预防疼痛与骨质疏松危险因素的识别、骨脆性的早期诊断和治疗密切相关。严重骨质疏松患者的疼痛管理也受益于非药物与药物治疗相结合的多维方法(例如,体育锻炼、营养、镇痛药和抗骨质疏松药物,视情况而定)。本综述旨在研究骨质疏松症疼痛的机制,并提供当前和新兴治疗策略的循证综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drugs & Aging
Drugs & Aging 医学-老年医学
CiteScore
5.50
自引率
7.10%
发文量
68
审稿时长
6-12 weeks
期刊介绍: Drugs & Aging delivers essential information on the most important aspects of drug therapy to professionals involved in the care of the elderly. The journal addresses in a timely way the major issues relating to drug therapy in older adults including: the management of specific diseases, particularly those associated with aging, age-related physiological changes impacting drug therapy, drug utilization and prescribing in the elderly, polypharmacy and drug interactions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信